Lithium
Lithium, Lithobid (lithium) is a small molecule pharmaceutical. Lithium was first approved as Lithobid on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| mental disorders | D001523 |
Trade Name
FDA
EMA
Lithium, Lithobid (discontinued: Eskalith, Lithane, Lithium, Lithonate, Lithotabs)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lithium carbonate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LITHOBID | ANI Pharmaceuticals | N-018027 RX | 1982-01-01 | 1 products, RLD, RS |
| LITHIUM CARBONATE | Hikma Pharmaceuticals | N-017812 RX | 1982-01-01 | 3 products, RLD |
| LITHIUM CARBONATE | Hikma Pharmaceuticals | N-018558 RX | 1982-01-29 | 1 products, RLD, RS |
Show 7 discontinued
Lithium citrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LITHIUM CITRATE | Hikma Pharmaceuticals | N-018421 DISCN | 1982-01-01 | 1 products, RLD |
| LITHONATE | Solvay Pharmaceuticals | N-017672 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| lithane | 2006-06-12 | |
| lithium | ANDA | 2024-12-11 |
| lithium carbonate | ANDA | 2024-12-12 |
| lithium carbonate extended release | 2007-03-30 | |
| lithium carbonate lithium carbonate | ANDA | 2022-11-24 |
| lithium lithium carbonate | New Drug Application | 2022-11-22 |
| lithobid | New Drug Application | 2022-10-28 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
LITHIUM CITRATE, LITHIUM CITRATE, RUBICON | |||
| 2024-03-18 | CGT | ||
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D11: Other dermatological preparations in atc
— D11A: Other dermatological preparations in atc
— D11AX: Other dermatological preparations in atc
— D11AX04: Lithium succinate
N: Nervous system drugs
— N05: Psycholeptics
— N05A: Antipsychotics
— N05AN: Lithium antipsychotics
— N05AN01: Lithium
HCPCS
Code | Description |
|---|---|
| A4235 | Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each |
| A4601 | Lithium ion battery, rechargeable, for non-prosthetic use, replacement |
| A4602 | Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each |
| E2397 | Power wheelchair accessory, lithium-based battery, each |
| K0604 | Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each |
| K0605 | Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each |
| L7367 | Lithium ion battery, rechargeable, replacement |
| L7368 | Lithium ion battery charger, replacement only |
| L8623 | Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each |
| L8624 | Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each |
Show 2 more
Clinical
Clinical Trials
422 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mania | D000087122 | — | — | — | — | 1 | — | — | 1 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | 1 | — | — | 1 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Lithium |
| INN | — |
| Description | Lithium Citrate, Lithonate (lithium) is a small molecule pharmaceutical. Lithium was first approved as Lithium Citrate on 1982-01-01. It is used to treat in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | [LiH] |
Identifiers
| PDB | — |
| CAS-ID | 7439-93-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2146126 |
| ChEBI ID | 30146 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
IMPA1
IMPA1
Organism
Homo sapiens
Gene name
IMPA1
Gene synonyms
IMPA
NCBI Gene ID
Protein name
inositol monophosphatase 1
Protein synonyms
D-galactose 1-phosphate phosphatase, IMP 1, IMPase 1, inositol(myo)-1(or 4)-monophosphatase 1, Inositol-1(or 4)-monophosphatase 1, Lithium-sensitive myo-inositol monophosphatase A1, myo-inositol monophosphatase 1, testicular tissue protein Li 94
Uniprot ID
Mouse ortholog
Impa1 (55980)
inositol monophosphatase 1 (O55023)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Lithium
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 57,153 documents
View more details
Safety
Black-box Warning
Black-box warning for: Lithane, Lithium, Lithium carbonate, Lithium carbonate lithium carbonate, Lithium lithium carbonate, Lithobid
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
21,639 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use